These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 3933538

  • 1. Plasminogen activator in psoriatic scales is of the tissue-type PA as identified by monoclonal antibodies.
    Grøndahl-Hansen J, Nielsen LS, Kristensen P, Grøndahl-Hansen V, Andreasen PA, Danø K.
    Br J Dermatol; 1985 Sep; 113(3):257-63. PubMed ID: 3933538
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin.
    Grøndahl-Hansen J, Ralfkiaer E, Nielsen LS, Kristensen P, Frentz G, Danø K.
    J Invest Dermatol; 1987 Jan; 88(1):28-32. PubMed ID: 3098860
    [Abstract] [Full Text] [Related]

  • 4. Urokinase-type plasminogen activator in endothelial cells during acute inflammation of the appendix.
    Grøndahl-Hansen J, Kirkeby LT, Ralfkiaer E, Kristensen P, Lund LR, Danø K.
    Am J Pathol; 1989 Oct; 135(4):631-6. PubMed ID: 2508479
    [Abstract] [Full Text] [Related]

  • 5. Plasminogen activation system in human milk.
    Heegaard CW, Larsen LB, Rasmussen LK, Højberg KE, Petersen TE, Andreasen PA.
    J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):159-66. PubMed ID: 9252902
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Urokinase-type plasminogen activator is increased in the involuting ventral prostate of castrated rats.
    Andreasen PA, Kristensen P, Lund LR, Danø K.
    Endocrinology; 1990 May; 126(5):2567-76. PubMed ID: 2109689
    [Abstract] [Full Text] [Related]

  • 8. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H.
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [Abstract] [Full Text] [Related]

  • 9. Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.
    Andreasen PA, Nielsen LS, Kristensen P, Grøndahl-Hansen J, Skriver L, Danø K.
    J Biol Chem; 1986 Jun 15; 261(17):7644-51. PubMed ID: 3086313
    [Abstract] [Full Text] [Related]

  • 10. Enzyme-linked immunosorbent assay for human urokinase-type plasminogen activator and its proenzyme using a combination of monoclonal and polyclonal antibodies.
    Nielsen LS, Grøndahl-Hansen J, Andreasen PA, Skriver L, Zeuthen J, Danø K.
    J Immunoassay; 1986 Jun 15; 7(3):209-28. PubMed ID: 3091639
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of the binding of plasminogen activators to plasma membranes from human liver.
    Nguyen G, Self SJ, Camani C, Kruithof EK.
    Biochem J; 1992 Nov 01; 287 ( Pt 3)(Pt 3):911-5. PubMed ID: 1445249
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Different receptors mediate the hepatic catabolism of tissue-type plasminogen activator and urokinase.
    Krause J, Seydel W, Heinzel G, Tanswell P.
    Biochem J; 1990 May 01; 267(3):647-52. PubMed ID: 2160232
    [Abstract] [Full Text] [Related]

  • 18. Urokinase and tissue-type plasminogen activators are present in breast cyst fluids.
    Macgregor IR, Miller WR.
    Eur J Cancer Clin Oncol; 1988 Jun 01; 24(6):985-9. PubMed ID: 3137078
    [Abstract] [Full Text] [Related]

  • 19. Hormonal regulation of the release of plasminogen activators and of a specific activator inhibitor from endometrial tissue in culture.
    Casslén B, Andersson A, Nilsson IM, Astedt B.
    Proc Soc Exp Biol Med; 1986 Sep 01; 182(4):419-24. PubMed ID: 3090554
    [Abstract] [Full Text] [Related]

  • 20. Characterization of a recombinant chimeric plasminogen activator composed of a fibrin fragment-D-dimer-specific humanized monoclonal antibody and a truncated single-chain urokinase.
    Vandamme AM, Dewerchin M, Lijnen HR, Bernar H, Bulens F, Nelles L, Collen D.
    Eur J Biochem; 1992 Apr 01; 205(1):139-46. PubMed ID: 1313361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.